Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.
Lymphatica Medtech has raised $19.6M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Lymphatica Medtech's investors include HTGF (High-Tech Gruenderfonds), CDP Venture Capital, Panakes Partners, Zúrcher Kantonal Bank, MassChallenge.
Lymphatica Medtech is headquartered in Ecublens, Switzerland.
Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.
Lymphatica Medtech is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lymphatica Medtech — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/lymphatica-medtech. Accessed July 19, 2026.
VCBacked. (2024). Lymphatica Medtech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/lymphatica-medtech
{{cite web |title=Lymphatica Medtech — Funding & Investors |url=https://www.vcbacked.co/company/lymphatica-medtech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated